Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,200 | 20,486 | 14,688 | 23,090 | 20,160 |
| Marketable Securities | 17,878 | 23,181 | 29,084 | 28,606 | 37,867 |
| Receivables | 432 | 438 | 129 | 198 | 189 |
| TOTAL | $36,661 | $44,821 | $44,987 | $52,633 | $59,141 |
| Non-Current Assets | |||||
| PPE Net | 1,101 | 1,070 | 1,154 | 1,308 | 1,376 |
| Other Non-Current Assets | 0 | 230 | 218 | 285 | 269 |
| TOTAL | $1,101 | $1,300 | $1,372 | $1,593 | $1,645 |
| Total Assets | $37,762 | $46,121 | $46,359 | $54,226 | $60,786 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,400 | 700 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,388 | 3,383 | 3,058 | 3,774 | 3,591 |
| TOTAL | $3,788 | $4,083 | $3,058 | $3,774 | $3,591 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,476 | 6,104 | N/A | N/A | N/A |
| TOTAL | $5,476 | $6,104 | $N/A | $N/A | $N/A |
| Total Liabilities | $9,264 | $10,187 | $3,058 | $3,774 | $3,591 |
| Shareholders' Equity | |||||
| Common Shares | 147,887 | 173,841 | 173,841 | 173,841 | 173,829 |
| Retained earnings | -177,143 | -173,388 | -165,323 | -157,581 | -150,201 |
| Other shareholders' equity | -990 | -990 | -990 | -990 | -990 |
| TOTAL | $28,498 | $35,934 | $43,301 | $50,452 | $57,195 |
| Total Liabilities And Equity | $37,762 | $46,121 | $46,359 | $54,226 | $60,786 |